Genetic and clinical characteristics of Korean patients with neurofibromatosis type 2.
- Author:
Hye ji KIM
1
;
Go Hun SEO
;
Yoon Myung KIM
;
Gu Hwan KIM
;
Eul Ju SEO
;
Young Shin RA
;
Jin Ho CHOI
;
Han Wook YOO
;
Beom Hee LEE
Author Information
- Publication Type:Original Article
- Keywords: Neurofibromatosis 2; Korea; Mutation
- MeSH: Clinical Coding; DNA; Exons; Genes, Neurofibromatosis 2; Humans; Korea; Lymphocytes; Multiplex Polymerase Chain Reaction; Neurofibromatoses*; Neurofibromatosis 2*; Neuroma, Acoustic; Peripheral Nerves; Peripheral Nervous System Neoplasms
- From:Journal of Genetic Medicine 2017;14(2):56-61
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: Neurofibromatosis type 2 (NF2) is characterized by multiple tumors, including vestibular schwannoma (VS) and others affecting cranial and peripheral nerves. NF2 is caused by mutation of the NF2 gene. The mutation spectrum of NF2 has not been characterized in Korean patients. In the current study, the clinical and genetic characteristics of Korean NF2 patients were analyzed. MATERIALS AND METHODS: Twenty-five unrelated Korean families were enrolled according to the Manchester criteria. Genetic analysis was performed by direct sequencing and multiplex ligation-dependent probe amplification methods using genomic DNA from peripheral lymphocytes or tumor tissues. RESULTS: All patients had bilateral/unilateral VS and/or other cranial and peripheral nerve tumors. Two patients were familial cases and the other 24 patients were sporadic. Germline NF2 mutations were detected in peripheral lymphocytes from both familial cases, but only in 26.1% of the 23 sporadic families. Somatic mutations were also found in tumor tissues from two of the sporadic families. These somatic mutations were not found in peripheral lymphocytes. A total of 10 different mutations including 2 novel mutations were found in 40.0% of studied families. Five mutations (50.0%) were located in exon 6 of NF2, the FERM domain coding region. CONCLUSION: Family history was an important factor in identifying germline NF2 mutations. Further study is required to investigate whether exon 6 is a mutation hotspot in Korean NF2 patients and its correlation to phenotypic severity.
